Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 51,822 |
|
|||||
| News | - | ||||||
| Day High | 2.87 | Low High |
|||||
| Day Low | 2.48 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Oncocyte Corporation | OCX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.2294 | 9.00% | 2.7794 | 16:12:55 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.53 | 2.48 | 2.87 | 2.7794 | 2.55 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 241 | 51,822 | US$ 2.68 | US$ 138,677 | - | 2.08 - 5.882 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 25 | US$ 2.73 | USD |
Oncocyte Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 22.96M | 8.26M | - | 7.27M | -28.72M | -3.48 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Oncocyte News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OCX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.49 | 2.87 | 2.3501 | 2.49 | 19,867 | 0.2894 | 11.62% |
| 1 Month | 2.84 | 3.30 | 2.285 | 2.70 | 152,220 | -0.0606 | -2.13% |
| 3 Months | 2.91 | 3.30 | 2.285 | 2.74 | 59,090 | -0.1306 | -4.49% |
| 6 Months | 2.58 | 4.34 | 2.08 | 2.83 | 37,114 | 0.1994 | 7.73% |
| 1 Year | 5.534 | 5.882 | 2.08 | 4.02 | 82,045 | -2.75 | -49.78% |
| 3 Years | 102.60 | 125.00 | 2.08 | 38.33 | 342,270 | -99.82 | -97.29% |
| 5 Years | 69.80 | 125.00 | 2.08 | 44.66 | 364,221 | -67.02 | -96.02% |
Oncocyte Description
| OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests. |
